Rachel Newsome

A small compound produced naturally by gut bacteria doubled the response to lung cancer immunotherapy treatment in mice.

Rachel Newsome will present her research on harnessing the gut microbiome to enhance the effectiveness of cancer immunotherapy treatment.

The award funds her research that harnesses gut microbiota in cancer immunotherapy response.

Rachel Newsome's research focuses on host-microbe interactions regarding inflammation, cancer and cancer therapeutics.

Rachel Newsome won for her research targeting the gut microbiome in lung cancer patients to improve their immune response.